
Medpace Holdings (MEDP) Stock Forecast & Price Target
Medpace Holdings (MEDP) Analyst Ratings
Bulls say
Medpace Holdings is projected to experience a significant increase in passthrough revenues, citing an anticipated rise of 200-300 basis points in the second half of the year compared to the elevated levels seen in the second quarter. The company has also reported a strong first quarter, marked by a higher volume of request for proposals (RFP), which indicates increasing demand for its services. Furthermore, Medpace expects its book-to-bill ratio to surpass 1.15x in the third quarter, reflecting robust business growth and operational strength.
Bears say
Medpace Holdings has experienced consistent backlog cancellations that have remained at or above the upper range of what the company deems acceptable, although they recently dropped toward the lower end of that range in Q2. The company's inability to quantify potential growth in Direct Service revenue raises concerns about future cash flows, despite a lack of expected significant decline by 2026. Adjusted EBITDA estimates for 2025 and 2026 have been revised upward, but these adjustments reflect increased direct service costs due to continued hiring, coupled with anticipated reductions in passthrough revenue, signaling underlying financial pressures.
This aggregate rating is based on analysts' research of Medpace Holdings and is not a guaranteed prediction by Public.com or investment advice.
Medpace Holdings (MEDP) Analyst Forecast & Price Prediction
Start investing in Medpace Holdings (MEDP)
Order type
Buy in
Order amount
Est. shares
0 shares